Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes
✍ Scribed by Lacey L. Sahuque; Erika F. Kullberg; Andrew J. Mcgeehan; Jennifer R. Kinder; Megan P. Hicks; Mary G. Blanton; Patricia H. Janak; M. Foster Olive
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 373 KB
- Volume
- 186
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Corticotropin‐releasing factor agonists exert inhibitory effects in stomach functions possibly through peripheral routes. We have previously reported the expression of Urocortin (Ucn) I, an endogenous ligand of both CRF receptor types CRF~1~ and CRF~2~, in the human stomach. We examined
The bed nucleus of the stria terminalis (BNST) has a high density of corticotropin-releasing hormone (CRH)-containing neurons that are significantly innervated by noradrenergic and dopaminergic nerve terminals. This limbic structure is involved in the extrahypothalamic response to stress. The purpos
## Abstract The bed nucleus of the stria terminalis (BST) is a limbic structure involved in regulating the hypothalamic‐pituitary‐adrenal axis as well as in central cardiovascular control. We report here on cardiovascular effects caused by microinjection of noradrenaline (NA) in the BST of the rat
## Abstract The bed nucleus of the stria terminalis (BST) plays a tonic role modulating the baroreflex bradycardiac response. In the present study, we verified whether local BST glutamatergic receptors and nitric oxide (NO) system modulate baroreflex bradycardiac responses. Bilateral BST‐ N‐methyl‐